Hydroxyapatite Crystal Deposition Disease (HADD)
WEBHydroxyapatite deposition disease (HADD) is a condition where hydroxyapatite crystals accumulate in the soft tissues surrounding joints, leading to inflammation, tenderness, and pain. It primarily affects women around the age of 45 and commonly affects the glenohumeral joint in the shoulder. Other joints such as the hip, knee, elbow, wrist, and ...
Facet Hypertrophy | Diagnosis & Disease Information
WEBSep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or …
Viscosupplementation for Knee Osteoarthritis - Rheumatology …
WEBMar 25, 2019 · Viscosupplementation is a medical procedure during which a gel-like fluid called hyaluronic acid is injected into the knee joint. Hyaluronic acid is a naturally occurring lubricant that allows for smoother joint movement. It is found in lower concentrations in patients with knee osteoarthritis.
Gout - Rheumatology Advisor
WEBAug 4, 2022 · Gout is the most common type of inflammatory arthritis in the world. Dietary, environmental, and genetic factors appear to play a role in disease pathogenesis which is reflected in the varying distributions of prevalence by region and demographic factors. Age is a major factor affecting prevalence, with rates increasing over the entire lifespan in men and after menopause in women.
Undifferentiated Connective Tissue Disease - Rheumatology Advisor
WEBUndifferentiated connective tissue disease (UCTD) is a diagnosis of exclusion. Patients who present with clinical and serolotical manifestations that suggest a systemic autoimmune disease but do not fulfill criteria for defined connective tissue disease (eg, systemic lupus erythematosus, scleroderma, myositis, rheumatoid arthritis, Sjogren's syndrome) are classified to have UCTD.
Ehlers-Danlos Syndrome - Rheumatology Advisor
WEBEhlers-Danlos syndrome is a group of inherited connective tissue disorders that primarily affects the skin, joints, and blood vessel walls 1 but can affect every organ system and result in significant morbidity and mortality. 2 Typical clinical manifestations are skin hyperelasticity, hypermobility of joints, the fragility of blood vessels, 2 ...
Rheumatoid Arthritis Injection Treatment Approved by FDA
WEBJune 5, 2017. Regeneron Pharmaceuticals, Inc., and Sanofi announced that the US Food and Drug Administration (FDA) has approved Kevzara (sarilumab) injection to treat adults with moderate to severe rheumatoid arthritis (RA). This treatment is recommended in patients with RA who have had an inadequate response or demonstrated intolerance to one ...
Calcium Pyrophosphate Deposition Disease (CPPD)
WEBOct 5, 2022 · Calcium pyrophosphate deposition disease (CPPD) is a crystal deposition arthropathy that involves the synovial and periarticular tissues, 1 often characterized by painful swelling in one or more joints. 2 Other names that have been traditionally used for CPPD are chondrocalcinosis, pyrophosphate arthropathy, and most especially, pseudogout. 3 ...
2022 ACR/AAHKS Guidelines for Management of
WEBApr 6, 2022 · The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) released updated guidelines for the perioperative management of antirheumatic medications among patients with rheumatic diseases undergoing elective total hip arthroplasty (THA) or total knee arthroplasty (TKA).
What Rheumatologists Need to Know About Cancer Risk in …
WEBApr 30, 2021 · In the United States, the lifetime risk of developing cancer is 1 in 3 individuals. 1 For patients with rheumatoid arthritis (RA), this risk may be increased due to the shared etiology between cancer and RA and the immunomodulatory nature of agents commonly used in RA treatment. 2 When determining appropriate therapeutic options for patients with RA and cancer, providers must make complex ...